Last reviewed · How we verify

Carboplatin Injection — Competitive Intelligence Brief

Carboplatin Injection (Carboplatin Injection) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Platinum-based chemotherapy agent. Area: Oncology.

marketed Platinum-based chemotherapy agent DNA Oncology Small molecule Live · refreshed every 30 min

Target snapshot

Carboplatin Injection (Carboplatin Injection) — Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Carboplatin is a platinum-based chemotherapy agent that forms DNA crosslinks, preventing cancer cell replication and inducing apoptosis.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Carboplatin Injection TARGET Carboplatin Injection Chia Tai Tianqing Pharmaceutical Group Co., Ltd. marketed Platinum-based chemotherapy agent DNA
CEDAZURIDINE CEDAZURIDINE marketed Nucleoside Metabolic Inhibitor [EPC] DNA methyltransferase 2020-01-01
Dacogen decitabine Sun Pharma marketed Nucleoside Metabolic Inhibitor [EPC] DNA (cytosine-5)-methyltransferase 1 2006-01-01
Vidaza azacitidine Bristol-Myers Squibb marketed Nucleoside Metabolic Inhibitor [EPC] DNA (cytosine-5)-methyltransferase 1 2004-01-01
Zymar GATIFLOXACIN Allergan marketed DNA gyrase, DNA gyrase, DNA gyrase subunit A 2003-01-01
Eloxatin Oxaliplatin Yakult Honsha marketed Platinum-based chemotherapy agent DNA 2002-01-01
Hepsera ADEFOVIR DIPIVOXIL Gilead Sciences marketed Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor DNA polymerase subunit gamma-1 2002-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape (Platinum-based chemotherapy agent class)

  1. Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · 3 drugs in this class
  2. Merck Sharp & Dohme LLC · 2 drugs in this class
  3. Federation Francophone de Cancerologie Digestive · 2 drugs in this class
  4. Sun Yat-sen University · 2 drugs in this class
  5. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · 1 drug in this class
  6. Chinese Academy of Medical Sciences · 1 drug in this class
  7. Biocad · 1 drug in this class
  8. Gruppo Oncologico Italiano di Ricerca Clinica · 1 drug in this class
  9. Celgene · 1 drug in this class
  10. Gao-jun Teng · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Carboplatin Injection — Competitive Intelligence Brief. https://druglandscape.com/ci/carboplatin-injection. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: